Nektar Therapeutics (NKTR) Stock Quote

Detailed Quote for Nektar Therapeutics (NKTR)

close 52 Week Information

52 Week High

February 14, 2011

Close: 11.25

52 Week Low

November 23, 2011

Close: 4.07

Today

Last Price
6.84

Change $
0.14

Change %
2.01%

Tick
N/A

Bid
N/A

Bid Size
0

Ask
N/A

Ask Size
0

Open
6.90

High
6.93

Low
6.76

Prev Close
6.98

Last Trade
2/10/12

Volume
719.42 k

52 Wk Hi
11.25

52 Wk Low
4.07

Market Cap
782.68 m

Ex-Div Date
N/A

Div Rate
N/A

Yield
N/A

Shares
114,426,466

EPS (TTM)
-1.10

PE Ratio
N/A

close Exchange Information Listed On Nasdaq Global Select (NGS) Exchange
NGS

News and Media for Nektar Therapeutics (NKTR)

Sector News | Topic News

News for NKTR

Fri, Jan 13, 2012

9:00 AM

A Forward Look, the Year Ahead -- Featured Research on Achillion Pharmaceuticals, Inc. and Nektar Therapeutics - Marketwire

Thu, Jan 05, 2012

9:19 AM

Baxter Initiates Phase I Clinical Trial of Longer-acting Recombinant FVIII Treatment for Hemophilia A - PR Newswire

Wed, Jan 04, 2012

6:26 PM

Nektar Therapeutics' President and CEO, Howard W. Robin, to Present at the 30th Annual J.P. Morgan Healthcare Conference in San Francisco, CA - PR Newswire

Tue, Dec 13, 2011

7:30 AM

Nektar Announces Positive Clinical Data from Second Phase 1 Clinical Study of NKTR-181, a Novel Opioid Analgesic Molecule to Treat Chronic Pain - PR Newswire

Mon, Dec 12, 2011

7:30 AM

Nektar Therapeutics Initiates Phase 3 BEACON Trial of NKTR-102 in Women with Metastatic Breast Cancer - PR Newswire

Thu, Dec 08, 2011

8:15 AM

Nektar Reports Affymax Announced FDA Advisory Committee Voted in Favor of Benefit/Risk Profile for Peginesatide for Treatment of Anemia in Chronic Kidney Disease Patients on Dialysis - PR Newswire

Tue, Nov 15, 2011

6:16 PM

NKTR-102 Demonstrates Synergistic Anti-Tumor Activity in Combination with Pegylated Liposomal Doxorubicin in Platinum-Resistant Ovarian Cancer - PR Newswire

Mon, Nov 14, 2011

8:00 AM

Positive Data for Nektar's New Mu-Opioid Analgesic Molecule to Treat Acute Pain Highlighted at Neuroscience 2011 - PR Newswire

Wed, Nov 02, 2011

4:15 PM

Nektar Therapeutics Reports Third Quarter 2011 Financial Results - PR Newswire

Wed, Oct 26, 2011

9:00 AM

Nektar to Announce Financial Results for the Third Quarter of 2011 on Wednesday, November 2, 2011, After Close of U.S.-Based Financial Markets - PR Newswire

8:16 AM

Drug Approval Rate Stagnant -- Nektar and ADVENTRX Look to Defy Odds - Marketwire

Wed, Oct 05, 2011

8:16 AM

Pipelines From Geron and Nektar Therapeutics Rich With Possible Blockbusters - Marketwire

Wed, Sep 21, 2011

9:05 AM

Nektar Presents Positive Data for Novel Opioid Analgesic, NKTR-181, at the 2011 American Academy of Pain Management Annual Meeting - PR Newswire

Tue, Sep 20, 2011

9:55 AM

Global Situation & Resulting Influences - Research Report on Achillion Pharmaceuticals, Inc. and Nektar Therapeutics - Marketwire

Wed, Sep 14, 2011

8:14 PM

Nektar Therapeutics' President and CEO, Howard W. Robin, to Present at the UBS 2011 Global Life Sciences Conference in New York City - PR Newswire

Fri, Sep 09, 2011

6:30 PM

Positive Results from Phase 2 Clinical Study of NKTR-102 in Metastatic Breast Cancer Presented in Oral Session at the ASCO 2011 Breast Cancer Symposium - PR Newswire

Thu, Sep 08, 2011

8:00 AM

Nektar Initiates Second Phase 1 Clinical Study Evaluating NKTR-181, A Novel Opioid Molecule, for Treatment of Chronic Pain - PR Newswire

Mon, Jan 11, 2010

9:12 AM

Jennerex Appoints Dr. Hoyoung Huh to Its Board of Directors - Canada Newswire

More News for NKTR >>

Tags for Nektar Therapeutics

Research stocks or mutual funds related to Nektar Therapeutics by keywords or tags. Find companies that have a similar focus to NKTR. The keywords below have been associated to NKTR by either user submission or electronic means.

nektar news release service annual report film commission media database pharma marketing pharma license news release distribution news release example pharmaceutical sales marketing pharmaceutical sales rep pharmaceutical reports reports financial Drugs pr agency film pr wire investor how to write a news release publicity pharmaceutical industry media contacts news release pharmaceutical jobs annual reports Healthcare internet marketing financial advisors pharmaceutical investor relations Common Stock Investors pharmaceutical consultancy pr web media relations pharmaceutical news pharma licensing writing a news release pharmaceutical research pharmaceutical company Pharmaceutical Preparation Manufacturing (325412) investment news release format investing software online pr media release pharmaceuticals media lists pharmaceutical marketing